Molecular analysis of oncogenes, ras family genes (N-ras, K-ras, H-ras), myc family genes (c-myc, N-myc) and mdm2 in natural killer cell neoplasms
- PMID: 12460470
- PMCID: PMC5926889
- DOI: 10.1111/j.1349-7006.2002.tb01234.x
Molecular analysis of oncogenes, ras family genes (N-ras, K-ras, H-ras), myc family genes (c-myc, N-myc) and mdm2 in natural killer cell neoplasms
Abstract
Natural killer (NK) cell neoplasms are rare diseases. Frequent abnormalities of the tumor suppressor genes Rb, p53, p15INK4B, p16INK4A and p14ARF have been reported. However, no oncogenes associated with tumorigenesis of NK cell neoplasms have been reported so far. We analyzed the status of oncogenes including N-ras, K-ras, H-ras, c-myc, N-myc and mdm2 by Southern blot, PCR-SSCP, western blot analysis and immunohistochemical staining. We analyzed four cell lines derived from NK cell neoplasms and 31 clinical samples with five subclasses of NK cell neoplasms. We found no point mutations of the ras family genes. We detected no mutations in the c-myc and N-myc genes. No overexpression of c-Myc protein was detected by western blot analysis. Although we found neither amplification nor rearrangement of the mdm2 gene, we found high expression of MDM2 protein in some cases by western blot analysis. Immunohistochemical staining confirmed the overexpression of MDM2 protein. We found 14 cases with overexpression of MDM2 protein out of 15 cases (93%) with four subclasses of NK cell neoplasms except chronic NK lymphocytosis. Our previous and these results suggested that the expression level of MDM2 protein is independent of the status of the p14ARF, p53, Rb genes. MDM2 protein might independently contribute to carcinogenesis of NK cell neoplasms. Although the number of the cases we analyzed was not large, alterations of ras and myc family genes may rarely contribute to tumorigenesis in NK cell neoplasms. In contrast, overexpression of MDM2 might be associated with tumorigenesis of NK cell neoplasms, especially aggressive subclasses.
Similar articles
-
Molecular analysis of tumor suppressor genes, Rb, p53, p16INK4A, p15INK4B and p14ARF in natural killer cell neoplasms.Jpn J Cancer Res. 2001 Oct;92(10):1048-56. doi: 10.1111/j.1349-7006.2001.tb01059.x. Jpn J Cancer Res. 2001. PMID: 11676855 Free PMC article.
-
Methylation status analysis of cell cycle regulatory genes (p16INK4A, p15INK4B, p21Waf1/Cip1, p27Kip1 and p73) in natural killer cell disorders.Eur J Haematol. 2005 May;74(5):424-9. doi: 10.1111/j.1600-0609.2005.00417.x. Eur J Haematol. 2005. PMID: 15813917
-
Genetic analysis of Raf1, Mdm2, c-Myc, Cdc25a and Cdc25b proto-oncogenes in 2',3'-dideoxycytidine- and 1,3-butadiene-induced lymphomas in B6C3F1 mice.Mutat Res. 2000 Jul 20;452(1):19-26. doi: 10.1016/s0027-5107(00)00031-2. Mutat Res. 2000. PMID: 10894886
-
Overexpression of the MDM2 oncogene in leukemia and lymphoma.Leuk Lymphoma. 1996 May;21(5-6):391-7, color plates XVI following 5. doi: 10.3109/10428199609093436. Leuk Lymphoma. 1996. PMID: 9172803 Review.
-
Osteosarcoma in blood relatives.Oncol Rep. 2001 Jan-Feb;8(1):131-6. doi: 10.3892/or.8.1.131. Oncol Rep. 2001. PMID: 11115584 Review.
Cited by
-
Leukemia and lymphoma of natural killer lineage cells.Int J Hematol. 2003 Jul;78(1):18-23. doi: 10.1007/BF02983235. Int J Hematol. 2003. PMID: 12894846 Review.
-
Regulating the p53 pathway: in vitro hypotheses, in vivo veritas.Nat Rev Cancer. 2006 Dec;6(12):909-23. doi: 10.1038/nrc2012. Nat Rev Cancer. 2006. PMID: 17128209 Review.
-
Integrated driver mutations profile of chinese gastrointestinal-natural killer/T-cell lymphoma.Front Oncol. 2022 Aug 18;12:976762. doi: 10.3389/fonc.2022.976762. eCollection 2022. Front Oncol. 2022. PMID: 36059700 Free PMC article.
-
RUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYC.Leukemia. 2017 Oct;31(10):2219-2227. doi: 10.1038/leu.2017.40. Epub 2017 Jan 25. Leukemia. 2017. PMID: 28119527 Free PMC article.
-
Favorable outcome in a child with EBV-negative aggressive NK cell leukemia.Int J Hematol. 2013 May;97(5):673-6. doi: 10.1007/s12185-013-1319-7. Epub 2013 Apr 4. Int J Hematol. 2013. PMID: 23550023
References
-
- ) Oshimi , K.Lymphoproliferative disorders of natural killer cells . Int. J. Hematol. , 63 , 279 – 290 ( 1996. ). - PubMed
-
- ) Suzuki , R. , Yamamoto , K. , Seto , M. , Kagami , Y. , Ogura , M. , Yatabe , Y. , Suchi , T. , Kodera , Y. , Morishima , Y. , Takahashi , T. , Saito , H. , Ueda , R. and Nakamura , S.CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity . Blood , 90 , 2417 – 2428 ( 1997. ). - PubMed
-
- ) DiGiuseppe , J. A. , Louie , D. C. , Williams , J. E. , Miller , D. T. , Griffin , C. A. , Mann , R. B. and Borowitz , M. J.Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study . Am. J. Surg. Pathol. , 21 , 1223 – 1230 ( 1997. ). - PubMed
-
- ) Jaffe , E. S. , Chan , J. K. , Su , I. J. , Frizzera , G. , Mori , S. , Feller , A. C. and Ho , F. C.Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas. Definitions, differential diagnosis, and epidemiology . Am. J. Surg. Pathol. , 20 , 103 – 111 ( 1996. ). - PubMed
-
- ) Imamura , N. , Kusunoki , Y. , Kawa , H. K. , Yumura , K. , Hara , J. , Oda , K. , Abe , K. , Dohy , H. , Inada , T. , Kajihara , H. and Kuramoto , A.Aggressive natural killer cell leukaemia/lymphoma: report of four cases and review of the literature. Possible existence of a new clinical entity originating from the third lineage of lymphoid cells . Br. J. Haematol. , 75 , 49 – 59 ( 1990. ). - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous